The effects of increased dietary calcium on the development of hypertension and vascular smooth muscle responses were studied in spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. Both hypertensive and normotensive animals were divided into two groups; the calcium content of the normal diet was 1.1% and that of the high calcium diet 3.1%. During the 12-week study, calcium supplementation significantly attenuated the increase in systolic blood pressure in the hypertensive rats but did not affect blood pressure in the normotensive rats. The contractile responses of endothelium-denuded mesenteric arterial rings to potassium chloride were similar in all study groups. The contractions to norepinephrine were not altered by the high calcium diet either, but smooth muscle sensitivity to this agonist was lower in the normotensive than in the hypertensive rats. Potassium relaxation was used to evaluate the activity of vascular smooth muscle Na + ,K + -ATPas«. The maximal rate of potassium relaxation was fastest in the normotensive groups but was also clearly faster in calcium-treated hypertensive rats when compared with hypertensive rats on a normal diet Platelets were used as a cell model for the analysis of intracellular free calcium concentration, which was measured by the fluorescent indicator quin-2. Intracellular free calcium was significantly reduced in the hypertensive rats by calcium supplementation and was not affected in the normotensive rats. In conclusion, a reduction of intracellular free calcium concentration indicating improved calcium regulation and a concomitant alteration in vascular relaxation probably reflecting increased activity of smooth muscle Na + ,K + -ATPase may contribute to the blood pressure-lowering effect of a high calcium diet (Hypertension 1992;19:85-92)
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The effects of increased dietary calcium on the development of hypertension and vascular smooth muscle responses were studied in spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. Both hypertensive and normotensive animals were divided into two groups; the calcium content of the normal diet was 1.1% and that of the high calcium diet 3.1%. During the 12-week study, calcium supplementation significantly attenuated the increase in systolic blood pressure in the hypertensive rats but did not affect blood pressure in the normotensive rats. The contractile responses of endothelium-denuded mesenteric arterial rings to potassium chloride were similar in all study groups. The contractions to norepinephrine were not altered by the high calcium diet either, but smooth muscle sensitivity to this agonist was lower in the normotensive than in the hypertensive rats. Potassium relaxation was used to evaluate the activity of vascular smooth muscle Na + ,K + -ATPas«. The maximal rate of potassium relaxation was fastest in the normotensive groups but was also clearly faster in calcium-treated hypertensive rats when compared with hypertensive rats on a normal diet Platelets were used as a cell model for the analysis of intracellular free calcium concentration, which was measured by the fluorescent indicator quin-2. Intracellular free calcium was significantly reduced in the hypertensive rats by calcium supplementation and was not affected in the normotensive rats. In conclusion, a reduction of intracellular free calcium concentration indicating improved calcium regulation and a concomitant alteration in vascular relaxation probably reflecting increased activity of smooth muscle Na + ,K + -ATPase may contribute to the blood pressure-lowering effect of a high calcium diet (Hypertension 1992;19:85-92) E pidemiological studies have suggested an inverse correlation between calcium intake and blood pressure, 1 ' 2 and a hypothesis has been developed whereby dietary calcium deficiency is associated with essential hypertension. 3 Both clinical and experimental studies suggest that blood pressure can be reduced by oral calcium supplementation. 4 - 6 However, contradictory results have also been published. 7 -8 The mechanisms underlying the possible blood pressure-lowering effect of calcium have not been fully clarified. Dietary calcium may correct the generalized membrane defect observed in hypertension and have a direct membrane-stabilizing effect on vascular smooth muscle, resulting in decreased conductance of ions across the cell membrane and reduced intracellular free calcium concentration. 6 -Calcium supplementation may also affect the overall sodium and calcium balance 1011 and lead to phosphate depletion, thus impairing cardiovascular regulation. 5 A high calcium diet has been found to reduce aortic smooth muscle reactivity in spontaneously hypertensive rats (SHR). 12 We have reported augmented smooth muscle relaxation with a concomitant reduction in tissue sodium/potassium ratio in calcium-supplemented SHR. 13 In the present study, we tested the hypothesis that dietary calcium alters functional properties of vascular smooth muscle. We investigated the effects of oral calcium supplementation on blood pressure and intracellular free calcium concentration in SHR and Wistar-Kyoto (WKY) rats and examined the associated changes in vascular smooth muscle reactivity.
groups (n=16 and n=9, respectively) of equal mean systolic blood pressures (155-156 and 144-145 mm Hg, respectively). Thus, the study groups were SHR, WKY rats, calcium-supplemented SHR (Ca-SHR), and calcium-supplemented WKY rats (Ca-WKY). An additional 24 SHR and 18 WKY rats on a normal calcium diet were used to study smooth muscle responses in vitro.
The rats were housed two animals to a cage and had free access to drinking fluid (tap water) and food pellets (Ewos, Sodertalje, Sweden) that in the SHR and WKY groups contained 1.1% calcium and in the Ca-SHR and Ca-WKY groups, 3.1% calcium (weight/weight, the extra calcium was supplied as carbonate salt). The consumption of food and drinking fluid was measured by weighing the chow and bottles, respectively.
The systolic blood pressures and heart rates of the unanesthetized animals were measured by the tailcuff method at +28°C (model 129 Blood Pressure Meter, IITC Inc., Woodland Hills, Calif.).
After 12 weeks of study, the rats were weighed, decapitated, and exsanguinated. The hearts were excised and weighed whole. Blood samples were drawn into chilled tubes on ice with heparin (100 units/ml, Sigma Chemical Co., St. Louis, Mo.) as anticoagulant.
For plasma electrolyte determinations, 2 ml blood was centrifuged (15 minutes, 1.000& +4°C), and the samples were stored at -70°C until assayed. Sodium, potassium, and calcium concentrations were analyzed with an atomic absorption spectrophotometer (AAS) (Spectr AA-30, Varian, Techtron Ltd., Victoria, Australia). In the calcium samples, lanthanum chloride (final concentration 5 mM) was used as ionization suppressant. This was prepared by dissolving La 2 O 3 (AAS grade, Aldrich Chemical Co., Milwaukee, Wis.) in concentrated hydrochloric acid and diluting it in deionized water.
Platelet Isolation and Measurement of Intracellular Free Calcium Concentration
Whole blood was diluted 1:2 with RPMI-1640 medium (Flow Laboratories, Irvine, Scotland), and 4 ml diluted sample was layered on 3 ml Ficoll-Paque solution (Pharmacia, LKB Biotechnology Inc., Piscataway, NJ.). After centrifugation (25 minutes, 120g +20°C), the supernatant was removed, and platelets and lymphocytes were harvested from the plasma-Ficoll interface. The cells were resuspended in 4 ml RPMI-1640 medium, and 0.4 ml ACD solution (8% citric acid, 2.2% trisodium citrate, 2.45% dextrose, pH 6.5) was added to the suspension. Lymphocytes were separated by centrifugation (10 minutes, lOOg, +20°C), and platelets were spun down from the supernatant (10 minutes, 500& +20°C). The platelets were washed twice with HEPES medium (in mM, NaCl 145, MgSO, 5, glucose 10, HEPES/NaOH 10, pH 7.4) by aspirating the cell pellet into a polypropylene Pasteur pipette and finally were resuspended in this medium.
The cell suspension (l-2xlO 9 platelets/ml) was loaded with 50 ^.M (final concentration) acetoxymethyl ester quin-2 (quin-2 AM, Aldrich) for 30 minutes at +37°C without shaking. Thereafter, the cell suspension was washed with 2 ml HEPES medium to remove extracellular quin-2. Finally, the platelets were resuspended in prewarmed (+37°C) Hanks' balanced salt solution (2-2.5 x 10 s platelets/ ml). After a 5-minute equilibration period, fluorescence was measured with a Shimadzu RF-5000 spectrofiuorometer (Shimadzu Corp., Kyoto, Japan) in quartz cuvettes with continuous stirring at +37°C. The excitation and emission wavelengths were set at 339 and 492 nm, respectively.
The calibration of intracellular fluorescence as a function of intracellular free calcium concentration ([Ca 2+ ]|) was performed essentially according to the method described by Tsien et al. 14 The maximal fluorescence (F,^) was measured after the addition of 2 fiM ionomycin (Sigma) and 5 mM calcium chloride (final concentrations), which saturated the binding capacity of quin-2. To measure the minimal fluorescence (F,^), 25 mM Tris-EGTA (final concentration), pH 8.6, and 0.1% (vol/vol) Triton X100 (Aldrich) were added to the suspension. The intracellular free calcium concentration was calculated by the equation
where 115 represents the dissociation constant in nanomoles and F is the fluorescence of the intact cell suspension.
Smooth Muscle Responses In Vitro
The mesenteric artery was excised and cleaned of connective tissue. A 3-mm-long standard section taken approximately 10 mm from the proximal part of the artery was cut, and the endothelium was removed by gently rubbing the preparation with a scuffled injection needle. The vascular ring was placed between two stainless steel hooks and was mounted in an organ bath chamber in physiological salt solution (PSS) (pH 7.4) of the following composition (mM): Nad 118.0, NaHCO 3 25.0, glucose 11.1, CaOz 2.5, KC1 4.7, KH2PO41.2, MgSO 4 1.2. The ring was equilibrated for 1 hour at +37°C with a resting tension of 1.5 g and was aerated with 95% O 2 and 5% CO 2 . The force of contraction was measured with an isometric force-displacement transducer (model FT03, Grass Instrument Co., Quincy, Mass.) and registered on a Grass polygraph (model 7 E Polygraph).
The removal of the endothelium was confirmed by adding 1 fiM acetylcholine (Sigma) to a norepinephrine (1 fiM) (Fluka Chemie AG, Buchs, Switzerland) precontracted vascular ring. If any relaxation was observed, the endothelium was further rubbed.
After a 30-minute stabilization period, dose-response curves for potassium chloride and norepinephrine were determined cumulatively for all preparations. In solutions containing high concentrations of potassium, Nad was substituted with KG on an equimolar basis.
After another 30 minutes of stabilization, potassium was omitted from the PSS. The K + -free solution was prepared by substituting KH 2 PO 4 and KC1 with NaH 2 PO 4 and NaO, respectively, on an equimolar basis (pH 7.4). The K + -free buffer solution resulted in a gradual contraction in all vascular preparations. After the contraction had reached a plateau, normal PSS (containing 5.9 mM potassium) was reintroduced to the preparations and the subsequent relaxation registered. The K + -free contraction and K + -relaxation scheme was also performed in some endothelium-intact preparations and in some endothelium-denuded preparations in the presence of 1 mM ouabain (Sigma) or after chemical sympathectomy; these preparations were obtained from SHR and WKY rats given a normal calcium diet. The vascular rings were denervated in vitro by exposing them to a buffer-free solution containing 1.2 mM 6-OH-dopamine (Sigma), and by vigorously gassing them with N 2 for 15 minutes, followed by a 2-hour recovery period in standard PSS. 15 After registration of responses, all preparations were dried overnight at +100°C and then were weighed. The concentration of agonist at which 50% of maximal force was developed (EQo) for norepinephrine and KC1 in each preparation was calculated from plots of the concentration of agonist versus the percentage of maximal tension response. Contractile responses in K + -free solution were normalized by comparing them with the maximal response to KG (124 mM KG). After potassium repletion, the greatest reduction in smooth muscle contractile force during a 1-minute period was considered as maximal relaxation rate, which was normalized by comparing it with the maximal 124 mM KG-induced contraction or by relating it to tissue dry weight. Only one vascular preparation from each animal was used in the study.
The experimental design was approved by the Animal Experimentation Committee of the University of Tampere.
Statistics
Statistical analysis was carried out using one-way analysis of variance (ANOVA), supported by Bonferroni confidence intervals in the case of pairwise comparisons between the test groups. When the data consisted of repeated observations at successive time points, ANOVA for repeated measurements was applied to study differences between groups. Comparisons were made between all groups or between two treatment groups as appropriate. The results are expressed as mean±SEM. The data were analyzed with BMDP Statistical Software, Los Angeles, Calif.
Results
During the 12-week study period, blood pressure increased in both SHR groups, whereas no significant change was observed in the WKY rat groups. final mean values for the four groups were: SHR 233±3, Ca-SHR 213±3, WKY 155±5, and Ca-WKY 153±4 mm Hg. When compared with SHR, the rise was significantly attenuated in the Ca-SHR group (/xO.0001, ANOVA for repeated measurements) ( Figure 1 ).
Calcium supplementation did not affect heart weight or heart rate in the SHR and WKY rats or growth in the SHR, but the Ca-WKY group gained slightly less weight than the WKY group. Heart rate and weight were significantly lower in the WKY groups, and the final body weight was higher when compared with the SHR groups. Based on food consumption, the mean intake of calcium was increased about fourfold in the Ca-SHR group when compared with the SHR group, and about threefold in the Ca-WKY when compared with the WKY group (Table 1) .
Plasma sodium concentrations were not affected by the high calcium diet but were slightly higher in both WKY groups than in the SHR groups. Plasma potassium was somewhat elevated in the Ca-SHR group. Plasma total calcium concentration was slightly higher in both WKY groups when compared with the SHR groups ( Table 1) .
The dose-response curves of contractions induced by potassium chloride and norepinephrine were not affected by the high calcium diet. For potassium chloride, both the EQo concentrations and the maximal contractile force related to tissue dry weight were quite comparable in all study groups ( Figure 2 , Table 2 ). However, the time required for total relaxation after 124 mM KG (i.e., the washout time) was markedly shorter in the WKY and Ca-WKY groups than in the SHR and Ca-SHR groups (Table 2 ). For norepinephrine, the WKY groups showed higher ECM concentrations (i.e., lower sensitivity), and the maximal contractile forces did not differ from those of the SHR groups ( Figure 2, Table 2 ). Typical responses of endothelium-denuded mesenteric arterial rings in K + -free solution are shown in Figure 3 , and plots of study groups in Figure 4 . The maximal contractile force generated in K + -free solution was similar in all study groups, but the plateau phase was reached earlier in the WKY, the Ca-WKY, and the Ca-SHR groups than in the SHR group. K + -relaxation time was shortest in the WKY groups, and that of the Ca-SHR group was also shorter than in the SHR group ( Figure 4 , Table 2 ). The maximal rate of relaxation was similar and clearly fastest in the WKY and Ca-WKY rats, and in the Ca-SHR it was also significantly faster than in the SHR given a normal diet ( Figure 5A ). Ouabain (1 mM) effectively prevented the K + -relaxation (data not shown), indicating that it reflected the activity of smooth muscle Na + ,K + -ATPase. FIGURE 
Line graphs show dose-response curves of endothelium-denuded mesenteric arterial rings to potassium chloride and norepinephrine. SHR, spontaneously hypertensive rats; WKY, Wistar-Kyoto rats; Co, calcium-supplemented animals (n=16 for SHR and Ca-SHR, and n=9 for WKY and Ca-WKY groups).
If the endothelium was left intact, the contractile response in K + -free solution was clearly depressed when compared with endothelium-denuded preparations in both SHR and WKY rats, but the contraction remained more pronounced in the SHR (Figure 3 , Table 3 ). In vitro sympathectomy with 6-OH-dopamine also markedly depressed the K + -free contractions of endothelium-denuded preparations, but the remaining contractions were clearly greater in the SHR than in the WKY rats ( Figure 3 , Table 3 ). The rate of potassium relaxation related either to maximal potassium chloride-induced contractile response or to tissue dry weight was always faster in the WKY than in the SHR, whether the endothelium or functioning adrenergic nerve endings were present or not (Table 3) . If potassium was returned to the bath before the plateau was reached, the maximal rate of relaxation was not noticeably affected (data not shown).
Platelet intracellular free calcium concentration, measured by the fluorescent indicator quin-2, was comparable in the WKY, Ca-WKY, and Ca-SHR groups and was significantly lower than in the SHR on the normal calcium diet ( Figure 5B ).
Discussion
In the present study, calcium supplementation lowered blood pressure in SHR, confirming earlier observations of our group and others. 5611 - 12 Blood pressure in normotensive WKY rats was not affected by the high calcium diet.
In accordance with previous findings, 12 -13 dietary calcium had no effect on body or heart weights of the SHR. Apparently, the reduction in afterload accompanying the lower blood pressure was not sufficient to attenuate cardiac hypertrophy. Weight gain was slightly impaired in the Ca-WKY group during the study, suggesting a nonbeneficial effect of increased 16 and in our study, the Ca-SHR group consumed about 30% more chow than the other groups, which resulted in an approximately fourfold increase in dietary calcium intake.
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FIGURE 3. Representative tracings show typical contractile responses of endothdium-intact (+endothdium), endotheliumdenuded (-endothdium), and endothdatm-aenuded+sympa-thectomized (-endothdium+sympathectomy) mesenteric arterial rings from spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats in K + -free buffer solution and the relaxation after the return of5.9 mMpotassium to the organ bath.
Extracellular ionized calcium values have been reported to be decreased both in essential hypertension and in SHR. 1718 We did not measure ionized but total plasma calcium concentration, which was also lower in SHR than in the normotensive controls and was not corrected by the high calcium diet. In contrast, plasma potassium concentration was elevated in the Ca-SHR group. The explanation for this is not clear from the present results, but in renovascular hypertension calcium supplementation has been reported to reduce blood pressure by suppressing the renin-angiotensin system. 19 If plasma renin was reduced in calcium-supplemented SHR, this could explain the slightly higher plasma potassium. Plasma sodium concentration was somewhat higher in both WKY groups than in the SHR and was not affected by the high calcium diet.
In the present study, the high calcium diet did not affect vascular sensitivity to vasoconstrictors, and maximal contractile responses to both potassium chloride and norepinephrine were also similar in SHR and WKY rats. However, smooth muscle sensitivity to norepinephrine but not to potassium chloride was lower in the WKY rats. This indicates increased sensitivity to a-adrenergic agonists in SHR, a finding reported in numerous studies (for review, see Reference 9) . We also found a clear difference in vascular smooth muscle relaxation; the washout time after maximal potassium chloride-induced contraction was markedly prolonged in both SHR groups when compared with the WKY groups, which could result from impaired calcium sequestration, extrusion, or contractile protein dephosphorylation in SHR smooth muscle.
The removal of extracellular potassium results in almost total inhibition of Na + ,K + -ATPase, 20 which can affect intracellular calcium and promote smooth muscle contraction in many ways: The inhibition results in increased intracellular sodium and decreased plasmalemmal sodium gradient, and thus in decreased extrusion of calcium by the Na + -Ca 2+ exchange mechanism. 21 Na + ,K + -ATPase inhibition also causes depolarization and increases the influx of calcium through potential-dependent channels. 20 The depolarization of vascular adrenergic nerves releases norepinephrine from the nerve endings, which activates a-adrenergic receptors and contributes to smooth muscle contraction. 22 In the present study with endothelium-denuded preparations, smooth muscle contraction after removal of extracellular potassium was more rapid in the WKY rats than in the SHR, and calcium supplementation shifted the response of the SHR in the normotensive direction. Both intact vascular endothelium and in vitro sympathectomy after removal of endothelium clearly depressed the contractile responses of vascular rings in K + -free solution, but the contractions remained more pronounced in the SHR than in the WKY rats. Thus, in the WKY rats an intact endothelium depresses more and adrenergic nerve endings participate more in the K + -free contractile response than in the SHR. The latter could reflect differences either in the function of adrenergic nerve endings or smooth muscle cell membrane. After sympathectomy, the greater K + -free contractions of endothelium-denuded preparations from the SHR most likely reflect increased intracellular accumulation of ions since cell membrane permeability has been found to be increased in the SHR. 69 The endothelium-denuded preparations were chosen to study ^-relaxation because they presented the greatest and fastest contractions. However, it should be pointed out that relaxation was always slower in SHR whether the endothelium or functioning adrenergic nerve endings were present or not.
The potassium-induced relaxation is an indirect means of measuring the activity of the sodium pump. When potassium is returned to the organ bath, the activation of Na + ,K + -ATPase repolarizes the cell membrane, 23 -24 initiating smooth muscle relaxation with calcium sequestration, extrusion, and contractile protein dephosphorylation. 25 Contrasting results on the activity of Na + ,K + -ATPase in hypertension have been reported, demonstrating sometimes an increase, 23 sometimes a decrease 26 in sodium pump activity. In the present study, potassium relaxation was •p<0.01, t/xO.001 compared with SHR using one-way analysis of variance.
clearly attenuated in SHR when compared with WKY rats. The present results support the conception of reduced Na + ,K + -ATPase activity in this type of genetic hypertension, although direct measurements of enzyme activity or electrical events were not performed. The high calcium diet significantly augmented the K + -relaxation response in the SHR; however, the relaxation after 124 mM KQ-induced contraction was not affected and remained prolonged. Thus, calcium treatment appears not to alter relaxation per se but augments the response to sodium pump blockade followed by potassium repletion. This supports alterations in the recovery of ionic gradients (e.g., intracellular sodium) in the Ca-SHR group, and more active Na + ,K + -ATPase, which could directly reduce peripheral resistance by hyperpolarizing the cell membrane and thus explain the blood pressure-lowering effect of oral calcium supplementation.
The intracellular free calcium concentration is elevated in lymphocytes and smooth muscle cells of SHR, 6 -27 and a cytoplasmic calcium-elevating factor has been found in the serum of SHR. 28 Increased intracellular calcium leads to augmented vascular contraction, raised peripheral resistance, and elevated blood pressure. Platelet intracellular free calcium has been reported to be elevated also in essential hypertension and to correlate well with the fall in blood pressure caused by antihypertensive therapy. 29 On the other hand, increased extracellular calcium in primary hyperparathyroidism has been associated with reduced intracellular free calcium. 30 In a recent study, calcium supplementation reduced intracellular free calcium in stroke-prone SHR, the proposed mechanism being the correction of the generalized membrane defect associated with genetic hypertension. 6 This membrane defect leads to increased permeability of the plasma membrane to major ions, which in turn enhances vascular contractions. 9 We have reported increased activity of red blood cell Ca 2+ -ATPase and reduced blood pressure in calciumsupplemented SHR. 13 In the present study, platelet intracellular free calcium was clearly lower in the WKY than in the SHR groups, and the high calcium diet reduced it in the SHR. The activation of calcium transport mechanisms or a direct effect on cell membrane could have contributed to the reduction in intracellular calcium.
It has been suggested that calcium can regulate sodium transport, an elevation in cytosolic calcium reducing and a decline enhancing the activity of Na + ,K + -ATPase. 31 Thus, in vascular tissue reduced intracellular free calcium would increase the activity of Na + ,K + -ATPase and reduce smooth muscle tone with this mechanism.
A circulating inhibitor of Na + ,K + -ATPase has been found in the plasma of both essentially hypertensive patients and rats with renovascular and saltinduced hypertension. 32 -34 This digjtalislike factor is thought to augment contractile responses in vascular smooth muscle and elevate peripheral resistance and blood pressure. 35 Increased dietary calcium has been reported to prevent salt-induced hypertension and to reduce plasma digitalislike immunoreactive factor in rats. 34 In the present study, calcium supplementation could have increased the activity of vascular Na + ,K + -ATPase in SHR by reducing the amount of this circulating sodium pump inhibitor.
In conclusion, the present results indicate that calcium supplementation attenuates the development of hypertension in SHR with concomitant alterations in intracellular free calcium concentration and vascular smooth muscle responses. Reduced intracellular free calcium indicates improved calcium regulation, and augmented potassium-relaxation rate suggests increased activity of smooth muscle Na + ,K + -ATPase.
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